|
25 July, 2013
|
ICON Reports second quarter 2013 Revenue of $334 million, up 21% year on year, non-GAAP EPS of 43c and raises FY 2013 Guidance.
|
|
|
23 July, 2013
|
ICON shareholders vote in favour of all resolutions at its Annual General Meeting
|
|
|
25 April, 2013
|
ICON Reports First Quarter 2013 Revenue of $317 Million, up 26% year on year and non-GAAP EPS of 36c.
|
|
|
24 April, 2013
|
ICON Wins ‘Partnership Pioneers of the Year' Award in Recognition of Global Partnership with Pfizer
|
|
|
21 February, 2013
|
ICON Announces Appointment of Professor William Hall to Board of Directors
|
|
|
19 February, 2013
|
ICON Reports Fourth Quarter 2012 Revenue of $300 Million, up 24% year on year, EPS of 34c and Full Year revenue of $1.12 billion, EPS of $1.00.
|
|
|
05 February, 2013
|
ICON Announces the Commencement of Direct Trading on NASDAQ
|
|
|
04 February, 2013
|
ICON To Acquire Clinical Trial Services Division of Cross Country Healthcare, Inc.
|
|
|
21 December, 2012
|
Mr. Thomas Lynch Elected as Chairman of ICON plc
|
|
|
18 December, 2012
|
ICON shareholders vote in favour of all resolutions at its Extraordinary General Meeting relating to the proposed conversion to a direct listing of ICON's shares on NASDAQ
|
|
|
03 December, 2012
|
ICON plc provides 2013 Financial Guidance ahead of Investor Day in New York
|
|
|
29 November, 2012
|
Dr. Bruce Given notifies ICON that he will not seek a further term as Chairman of the Board
|
|
|
16 November, 2012
|
ICON Announces Publication of EGM Circular in Respect of Proposed Conversion to Direct Listing of its Shares on NASDAQ
|
|
|
01 November, 2012
|
ICON Reports Q3 Revenue of $286 Million, EPS of 29c and Net New Business of $450 Million. (NASDAQ: ICLR) (ISIN:IE0005711209)
|
|
|
05 September, 2012
|
ICON Forms Strategic Partnership with University College Dublin
|
|
|
24 July, 2012
|
ICON Reports second quarter 2012 revenue up 19% to $277 million and non-GAAP EPS of 21c (NASDAQ:ICLR) (ISIN:IE0005711209)
|
|
|
20 July, 2012
|
ICON Shareholders Vote in Favour of All Resolutions at Its Annual General Meeting
|
|
|
12 June, 2012
|
ICON Announces Peter Gray to Retire from ICON Board of Directors
|
|
|
24 April, 2012
|
ICON reports a 10% increase in first quarter 2012 revenue to $252m, up 10% year on year, EPS of 15 cents, net new business awards of $385 million and a B:B of 1.5. (NASDAQ:ICLR) (ISIN:IE0005711209)
|
|
|
05 March, 2012
|
ICON Selected by Roche for Technology Partnership
|
|
